Product Information
DAPSONE 7.5% GEL PUMP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.7152 per GM under NDC 00378483060. Its NADAC has been published 222 times since Jul 6, 2022.
FDA first approved this application on Feb 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/g
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378483060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DAPSONEApproval Type
Generic (ANDA)
FDA Application
ANDA213847FDA Approved
2/4/2022
TE Code
AB
On Market Since
5/20/2022
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 7.5% GEL PUMP has been published 222 times since Jul 6, 2022, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7152 per GM |
|---|---|
| All-time high | $6.7176 (Aug 10, 2022) |
| All-time low | $0.7152 (Sep 23, 2026) |
| 52-week high | $1.2652 |
| 52-week low | $0.7152 |
| Median price | $1.6813 |
| Average price | $1.9881 |
| Largest weekly change | +46.0% (Jan 18, 2023) |
| Weeks tracked | 222 |
| Tracking since | Jul 6, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAPSONE 7.5% GEL PUMP?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 7.5% GEL PUMP, manufactured by Mylan Pharmaceuticals Inc., is $0.7152 per GM (NDC 00378483060), effective Sep 30, 2026.
How has the price of DAPSONE 7.5% GEL PUMP changed over time?
Over the history we have for it, the NADAC for DAPSONE 7.5% GEL PUMP has declined 89.4%. It has been tracked across 222 weekly CMS publications since Jul 6, 2022.
What are the highest and lowest recorded NADAC prices for DAPSONE 7.5% GEL PUMP?
Since Jul 6, 2022, the NADAC for DAPSONE 7.5% GEL PUMP has ranged from a low of $0.7152 (Sep 23, 2026) to a high of $6.7176 (Aug 10, 2022), with a median of $1.6813 per GM.
Are there cheaper alternatives to DAPSONE 7.5% GEL PUMP?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DAPSONE 7.5% GEL PUMP in a comparable dosage form, but none are currently priced below it.
Who manufactures DAPSONE 7.5% GEL PUMP?
DAPSONE 7.5% GEL PUMP (NDC 00378483060) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.